title: Interplay of LRRK2 with chaperone-mediated autophagy.
abstract: Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of familial Parkinson's disease. We found LRRK2 to be degraded in lysosomes by chaperone-mediated autophagy (CMA), whereas the most common pathogenic mutant form of LRRK2, G2019S, was poorly degraded by this pathway. In contrast to the behavior of typical CMA substrates, lysosomal binding of both wild-type and several pathogenic mutant LRRK2 proteins was enhanced in the presence of other CMA substrates, which interfered with the organization of the CMA translocation complex, resulting in defective CMA. Cells responded to such LRRK2-mediated CMA compromise by increasing levels of the CMA lysosomal receptor, as seen in neuronal cultures and brains of LRRK2 transgenic mice, induced pluripotent stem cell-derived dopaminergic neurons and brains of Parkinson's disease patients with LRRK2 mutations. This newly described LRRK2 self-perpetuating inhibitory effect on CMA could underlie toxicity in Parkinson's disease by compromising the degradation of α-synuclein, another Parkinson's disease-related protein degraded by this pathway.
authors: Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York, USA.
authors: Samantha J
authors: SJ
authors: Orenstein
authors: Sheng-Han
authors: SH
authors: Kuo
authors: Inmaculada
authors: I
authors: Tasset
authors: Esperanza
authors: E
authors: Arias
authors: Hiroshi
authors: H
authors: Koga
authors: Irene
authors: I
authors: Fernandez-Carasa
authors: Etty
authors: E
authors: Cortes
authors: Lawrence S
authors: LS
authors: Honig
authors: William
authors: W
authors: Dauer
authors: Antonella
authors: A
authors: Consiglio
authors: Angel
authors: A
authors: Raya
authors: David
authors: D
authors: Sulzer
authors: Ana Maria
authors: AM
authors: Cuervo
mesh_terms: D000369:Aged, 80 and over; D000818:Animals; D000831:Animals, Newborn; D001343:Autophagy / Q000502:physiology*; D001923:Brain Chemistry / Q000235:genetics / Q000502:physiology; D002478:Cells, Cultured; D005260:Female; D057809:HEK293 Cells; D006801:Humans; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D008875:Middle Aged; D018832:Molecular Chaperones / Q000235:genetics / Q000378:metabolism*; D009154:Mutation / Q000502:physiology; D011485:Protein Binding / Q000502:physiology; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D018832:Molecular Chaperones; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; C495279:Lrrk2 protein, mouse; D017346:Protein Serine-Threonine Kinases